Expanded Carrier Screening Global Market Report 2025
상품코드:1855872
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 확대 캐리어 스크리닝 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 21억 1,000만 달러에서 2025년에는 24억 6,000만 달러에 달하고, CAGR 16.9%로 확대될 것으로 보입니다. 기간 중 성장은 유전성 질환에 대한 인식 증가, 유전 상담 서비스의 폭넓은 이용가능성, 생식 의료에서의 조기 진단 수요 증가, 출생 전 및 임신 전 검사 프로그램의 확대, 예방 헬스케어에 대한 기호의 고조에 기인하고 있습니다.
확대 캐리어 스크리닝 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 16.5%로 확대되어 45억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간 중 성장의 원동력은 개별화 생식의료에 대한 수요 증가, 신흥 시장에 있어서의 확대 캐리어 스크리닝 채용 증가, 가정용 유전자 검사 키트에의 소비자의 액세스 확대, 고용주 부담의 유전자 검사 급부금 증가, 다문화 집단에 있어서의 보인자 동정 수요 고조입니다. 예측 기간의 주요 동향으로는 차세대 시퀀싱의 진전, AI를 활용한 유전 위험 예측 모델의 개발, 포인트 오브 케어 유전자 검사 플랫폼의 구축, 전자 의료 기록과의 통합, 다중화 유전자 검사 플랫폼의 혁신 등이 있습니다.
유전성 질환의 유병률 증가는 확대 캐리어 스크리닝 시장의 성장에 기여합니다. 이러한 질환은 개인의 DNA의 돌연변이나 이상에 의해 유발되며 유전될 수 있거나 자연스럽게 발생할 수 있습니다. 진단 기술, 특히 차세대 시퀀싱의 진보는 이전에 진단되지 않았거나 잘못 분류된 것을 포함하여 보다 광범위한 유전성 질환을 검출하는 능력을 향상시키고 있습니다. 확대 캐리어 스크리닝은 증상이 나타나기 전에 유전 질환을 가진 개인을 확인함으로써 정보에 근거한 생식 계획을 가능하게 하고, 유전 질환을 미래 세대에 이어갈 위험을 줄여줍니다. 예를 들어, Cystic Fibrosis Trust는 2024년 10월 낭포성 섬유증 등록 환자 수가 2022년 1만 1,148명에서 2023년 1만 1,318명으로 전년대비 1.5% 증가했다고 보고했습니다. 이 트렌드는 종합적인 유전자 스크리닝에 대한 요구 증가를 부각시키고 시장 성장을 뒷받침하고 있습니다.
확대 캐리어 스크리닝 시장의 각 회사는 광범위한 유전 질환을 검출하도록 설계된 고정밀 다유전자 패널 개발을 통해 유전자 검사를 진행하고 있습니다. 이러한 종합적인 차세대 시퀀싱(NGS) 기반 패널은 여러 유전자를 동시에 분석하여 유전적 위험을 파악하는 데 더 높은 정확성과 효율성을 제공합니다. 2023년 2월 미국에 본사를 둔 유전체 검사 회사인 Fulgent Genetics Inc.는 심각한 유전 질환과 관련된 787 유전자를 평가하는 Beacon787 확대 캐리어 스크리닝 패널을 발표했습니다. 모든 Tier 3 유전자를 포함한 700개 이상의 상염색체 열성 및 X 연쇄성 질환을 다루는 이 패널은 고급 NGS 기술을 사용하여 높은 분석 정확도, 범민족 관련성, 2-3주 납기를 제공합니다. 이 솔루션은 생식 유전 스크리닝의 가장 정확하고 종합적인 선택 중 하나로 자리매김되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 확대 캐리어 스크리닝 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 확대 캐리어 스크리닝 시장 : 성장률 분석
세계의 확대 캐리어 스크리닝 시장 실적 : 규모와 성장, 2019-2024년
세계의 확대 캐리어 스크리닝 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 확대 캐리어 스크리닝 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 확대 캐리어 스크리닝 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
커스터마이즈 패널 검사
프리디자인 패널 검사
세계의 확대 캐리어 스크리닝 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
데옥시리보 핵산(DNA) 시퀀싱
폴리메라아제 연쇄반응
마이크로어레이
기타 기술
세계의 확대 캐리어 스크리닝 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
임신 전
출생 전
기타 용도
세계의 확대 캐리어 스크리닝 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
진단 실험실
연구기관
전문 클리닉
기타 최종 사용자
세계의 확대 캐리어 스크리닝 시장 : 커스터마이즈 패널 검사 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
단일 유전자 검사
다중 유전자 패널 검사
민족 기반 맞춤 패널
병태 특이적 커스텀 패널
가족력 기반 커스텀 패널
세계의 확대 캐리어 스크리닝 시장 : 프리디자인 패널 검사 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
범민족 패널
유니버설 캐리어 패널
집단 특이적 패널
질병 포커스 패널
확장 사전정의 패널
제7장 지역별/국가별 분석
세계의 확대 캐리어 스크리닝 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 확대 캐리어 스크리닝 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
확대 캐리어 스크리닝 시장 : 경쟁 구도
확대 캐리어 스크리닝 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Labcorp Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Quest Diagnostics Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Illumina Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Natera Inc.
Myriad Genetics Inc.
Fulgent Genetics Inc.
BGI Genomics Co. Ltd.
Ambry Genetics Corporation
GeneDx Inc.
BillionToOne Inc.
MedGenome Labs Ltd.
Centogene NV
Baylor Miraca Genetics Laboratories LLC
Victorian Clinical Genetics Services
Pathkind Diagnostics Private Limited
Medicover Genetics GmbH
NxGen MDx LLC
GeneTech
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
확대 캐리어 스크리닝 시장(2029년) : 새로운 기회를 제공하는 국가
확대 캐리어 스크리닝 시장(2029년) : 새로운 기회를 제공하는 부문
확대 캐리어 스크리닝 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Expanded carrier screening refers to a genetic test that examines a wide panel of genes to determine if individuals carry mutations linked to inherited genetic disorders. It is commonly used before or during pregnancy to evaluate the risk of passing genetic conditions to offspring, irrespective of ethnicity or family history.
The primary types of expanded carrier screening are customized panel testing and pre-designed panel testing. Customized panel testing involves genetic tests tailored to an individual's family history, ethnicity, or specific medical needs to identify potential carrier risks. These tests utilize technologies such as DNA sequencing, polymerase chain reaction (PCR), microarrays, and others. Applications include preconception and prenatal screening. Key end-users include hospitals, diagnostic laboratories, research laboratories, specialty clinics, and related facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The expanded carrier screening market research report is one of a series of new reports from The Business Research Company that provides expanded carrier screening market statistics, including expanded carrier screening industry global market size, regional shares, competitors with a expanded carrier screening market share, detailed expanded carrier screening market segments, market trends and opportunities, and any further data you may need to thrive in the expanded carrier screening industry. This expanded carrier screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The expanded carrier screening market size has grown rapidly in recent years. It will grow from $2.11 billion in 2024 to $2.46 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period is attributed to increasing awareness of genetic disorders, wider availability of genetic counseling services, rising demand for early diagnosis in reproductive health, expansion of prenatal and preconception testing programs, and growing preference for preventive healthcare.
The expanded carrier screening market size is expected to see rapid growth in the next few years. It will grow to $4.54 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period is driven by increasing demand for personalized reproductive medicine, rising adoption of expanded carrier screening in emerging markets, greater consumer access to at-home genetic testing kits, growth in employer-sponsored genetic testing benefits, and a rising need to identify carriers in multicultural populations. Key trends in the forecast period include advancements in next-generation sequencing, development of AI-powered genetic risk prediction models, creation of point-of-care genetic testing platforms, integration with electronic health records, and innovations in multiplexed genetic testing platforms.
The increasing prevalence of genetic diseases is contributing to the growth of the expanded carrier screening market. These diseases, caused by mutations or abnormalities in an individual's DNA, may be inherited or arise spontaneously. Advances in diagnostic technologies, particularly next-generation sequencing, have improved the ability to detect a broader range of genetic disorders, including those that previously went undiagnosed or misclassified. Expanded carrier screening identifies individuals who carry genetic conditions before symptoms are present, allowing for informed reproductive planning and reducing the risk of passing inherited conditions to future generations. For example, in October 2024, the Cystic Fibrosis Trust reported that the number of registered cystic fibrosis patients increased from 11,148 in 2022 to 11,318 in 2023, a 1.5% year-over-year rise. This trend highlights the growing need for comprehensive genetic screening, supporting market growth.
Companies in the expanded carrier screening market are advancing genetic testing through the development of high-accuracy, multi-gene panels designed to detect a wide range of inherited disorders. These comprehensive next-generation sequencing (NGS)-based panels analyze multiple genes simultaneously, offering greater accuracy and efficiency in identifying genetic risks. In February 2023, Fulgent Genetics Inc., a U.S.-based genomic testing company, introduced the Beacon787 Expanded Carrier Screening Panel, which assesses 787 genes associated with severe inherited conditions. Covering over 700 autosomal recessive and X-linked disorders, including all Tier 3 genes, the panel uses advanced NGS technology to provide high analytical accuracy, pan-ethnic relevance, and a turnaround time of two to three weeks. This solution is positioned as one of the most precise and inclusive options for reproductive genetic screening.
In January 2024, Natera Inc., a U.S.-based genetic testing company, acquired reproductive health assets from Invitae Corporation for $52.5 million. This acquisition aims to enhance Natera's reproductive health offerings by incorporating Invitae's carrier screening and non-invasive prenatal testing services. The move allows Natera to strengthen its position in the reproductive genetics space, while Invitae shifts its focus toward core areas in oncology and rare disease testing. Invitae Corporation provides a broad range of genetic testing services, including carrier screening, diagnostic testing, and hereditary disease analysis.
North America was the largest region in the expanded carrier screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in expanded carrier screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the expanded carrier screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The expanded carrier screening market consists of revenues earned by entities by providing services such as genetic panel testing, counseling services, bioinformatics analysis, sample collection and processing, and customized panel design. The market value includes the value of related goods sold by the service provider or included within the service offering. The expanded carrier screening market also includes sales of next-generation sequencing (NGS) panels, microarray-based screening kits, sample collection kits, lab automation systems, and genotyping assays. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Expanded Carrier Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on expanded carrier screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for expanded carrier screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The expanded carrier screening market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types: Customized Panel Testing; Predesigned Panel Testing
2) By Technology: Deoxyribonucleic Acid Sequencing; Polymerase Chain Reaction; Microarrays; Other Technologies
3) By Application: Preconception; Prenatal; Other Applications
4) By End-User: Hospitals; Diagnostic Laboratories; Research Laboratories; Specialty Clinics; Other End-Users
Subsegments:
1) By Customized Panel Testing: Single Gene Testing; Multi-Gene Panel Testing; Ethnicity-Based Custom Panels; Condition-Specific Custom Panels; Family History-Based Custom Panels
3. Expanded Carrier Screening Market Trends And Strategies
4. Expanded Carrier Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Expanded Carrier Screening Growth Analysis And Strategic Analysis Framework
5.1. Global Expanded Carrier Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Expanded Carrier Screening Market Growth Rate Analysis
5.4. Global Expanded Carrier Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Expanded Carrier Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Expanded Carrier Screening Total Addressable Market (TAM)
6. Expanded Carrier Screening Market Segmentation
6.1. Global Expanded Carrier Screening Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Customized Panel Testing
Predesigned Panel Testing
6.2. Global Expanded Carrier Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid Sequencing
Polymerase Chain Reaction
Microarrays
Other Technologies
6.3. Global Expanded Carrier Screening Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preconception
Prenatal
Other Applications
6.4. Global Expanded Carrier Screening Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Research Laboratories
Specialty Clinics
Other End-Users
6.5. Global Expanded Carrier Screening Market, Sub-Segmentation Of Customized Panel Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Gene Testing
Multi-Gene Panel Testing
Ethnicity-Based Custom Panels
Condition-Specific Custom Panels
Family History-Based Custom Panels
6.6. Global Expanded Carrier Screening Market, Sub-Segmentation Of Predesigned Panel Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pan-Ethnic Panels
Universal Carrier Panels
Population-Specific Panels
Disorder-Focused Panels
Expanded Predefined Panels
7. Expanded Carrier Screening Market Regional And Country Analysis
7.1. Global Expanded Carrier Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Expanded Carrier Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
